Related Experiment Video

Updated: May 30, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

N-acetylcysteine modulates the cytotoxic effects of Paclitaxel

Patricia Anne Lyle1, Panagiotis Mitsopoulos, Zacharias E Suntres

  • 1Medical Sciences Division, Northern Ontario School of Medicine, Thunder Bay, Canada.

Chemotherapy
|July 23, 2011
PubMed
Abstract

Insights

N-acetylcysteine (NAC) protects against paclitaxel-induced cell death by reducing reactive oxygen species (ROS) and apoptosis. NAC modulates key apoptotic proteins, altering paclitaxel

Area of Science:

  • Cell Biology
  • Pharmacology
  • Biochemistry

Background:

  • Paclitaxel is a chemotherapy agent that induces cell cycle arrest and apoptosis by stabilizing microtubules.
  • Paclitaxel treatment elevates reactive oxygen species (ROS) levels, contributing to both apoptosis and necrosis.
  • N-acetylcysteine (NAC) is an antioxidant that can mitigate ROS-induced cellular damage and influence apoptotic pathways.

Purpose of the Study:

  • To investigate the protective effects of N-acetylcysteine (NAC) against paclitaxel-induced cytotoxicity in human lung adenocarcinoma cells.
  • To determine how NAC influences paclitaxel-mediated changes in reactive oxygen species (ROS) production and apoptosis.
  • To examine NAC's impact on the expression of key apoptotic regulatory proteins following paclitaxel exposure.

Main Methods:

  • A549 human adenocarcinoma alveolar epithelial cells were utilized.
  • Cells were treated with N-acetylcysteine (NAC), paclitaxel, or a combination of both for 24 hours.
  • Cell viability, intracellular ROS levels, and apoptosis were measured to assess treatment effects.

Main Results:

  • Paclitaxel treatment led to a dose- and time-dependent reduction in cell viability and increased ROS and apoptosis.
  • Co-treatment with NAC abrogated the cytotoxic effects of paclitaxel, preserving cell viability and reducing ROS and apoptosis.
  • NAC decreased paclitaxel-induced increases in activated caspase-10 but potentiated the activation of caspase-3.

Conclusions:

  • N-acetylcysteine (NAC) effectively counteracts paclitaxel-induced cytotoxicity in vitro.
  • NAC mitigates paclitaxel's effects by lowering ROS levels and inhibiting apoptosis.
  • NAC modulates specific apoptotic effector proteins, influencing the overall cell death pathway.

More Related Videos

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice08:41

Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice

Published on: October 27, 2014

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...